Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Diagnos ( (TSE:ADK) ) has provided an announcement.
Diagnos Inc. has announced an amendment to the terms of its unsecured convertible debentures, extending the maturity date from March 1, 2025, to March 1, 2026, and increasing the interest rate from 8% to 10% for the extended period. This amendment is subject to acceptance by the TSX Venture Exchange and aims to adjust financial terms to better align with market conditions, potentially impacting investor relations and financial strategy.
More about Diagnos
DIAGNOS is a publicly-traded Canadian corporation specializing in the development of software tools for the early detection of critical health issues using Artificial Intelligence.
YTD Price Performance: 13.33%
Average Trading Volume: 220,964
Technical Sentiment Consensus Rating: Hold
Current Market Cap: C$34.37M
See more data about ADK stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money